The life science industry has never moved faster, and the pace is only accelerating. Pipelines in oncology, rare disease, and cell and gene therapy are advancing with unprecedented velocity. Regulatory timelines are tightening, and the volume of new data is overwhelming traditional workflows. For medical communications agencies, this isn’t just about “keeping up.” It’s about …
Continue reading “Beyond Deadlines: The Growing Demands on MedComms”